Malignant melanoma in organ transplant recipients: incidence, outcomes, and management strategies: a review of literature

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064211%3A_____%2F16%3AN0000024" target="_blank" >RIV/00064211:_____/16:N0000024 - isvavai.cz</a>
Alternative codes found
RIV/00023001:_____/16:00059669 RIV/00216208:11130/16:10323748
Result on the web
<a href="https://www.ncbi.nlm.nih.gov/pubmed/26460720" target="_blank" >https://www.ncbi.nlm.nih.gov/pubmed/26460720</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/dth.12276" target="_blank" >10.1111/dth.12276</a>

Result language
angličtina
Original language name
Malignant melanoma in organ transplant recipients: incidence, outcomes, and management strategies: a review of literature
Original language description
Malignant melanoma is considered to be an immunogenic tumor, which is expected to change its behaviour in the field of immunosuppression. Although the incidence of melanoma in organ transplant recipients is increased to a smaller degree than in non-melanoma skin cancer, its potential morbidity and mortality has to be considered in the posttransplant care. The aim of this review is to investigate the relationship between melanoma and immunosuppression and to discuss management strategies for different melanoma scenarios in pre-transplant as well as posttransplant period.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FO - Dermatology and venereology
OECD FORD branch
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)